NCT Number: NCT04860583
Nephrocalcinosis in Very Low Birth Weight Infants
Extremely premature children benefit from specific follow-up that requires high nutritional intake and the use of specific therapies that expose them to the risk of nephrocalcinosis. Other identified risk factors are extreme prematurity and intrauterine growth restriction.
The incidence of nephrocalcinosis in very premature infants is unclear, ranging from 7 to 64%. Most studies are observational and only few case-control studies can properly analyse the risk factors for nephrocalcinosis in significant populations that include only preterm infants.
This nephrocalcinosis of prematurity regresses spontaneously in more than half of the cases, but has been associated with a risk of long-term complications: impaired renal function, high blood pressure, etc. This is an aggravating factor in the context of prematurity, which has been associated with an increased risk of renal impairment and hypertension in childhood and adulthood.
For all these reasons, nutritional intakes and therapeutics are monitored very closely and a renal ultrasound is routinely performed at discharge at 35 weeks of corrected gestational age in all children who are born at a gestational age ≤ 32 weeks and/or birth weight ≤ 1500 g.
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Observational
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Newborns with a gestational age <= 32 weeks and/or birthweight <=1500g
Exclusion criteria
- Newborns with kidney malformation
Treatment and study plan
Primary outcomes
-
Prevalence of nephrocalcinosis
Time frame: At week 35 of corrected gestational age
Presence/absence of nephrocalcinosis will be checked by ultrasound
Sponsors and collaborators
Lead sponsor
Hospices Civils de Lyon
Other
Registry information
Official study title
Nephrocalcinosis in Very Low Birth Weight Infants: an Observational Study
Important dates
- Study start
- 2012
- Primary completion
- 2020
- Study completion
- 2020
- First posted
- Apr 27, 2021
- Registry last updated
- Apr 27, 2021
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Review of Infant Oral Feeding and Skills
NCT06736743
Behavior, Bottle Feeding
Chicago, Illinois, United States
View Trial DetailsA Multicenter and Prospective Study of Screening Retinopathy of Prematurity in China
NCT06729333
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Shanghai, China
View Trial DetailsEffects of Antimuscarinic Drugs on Ejaculation Duration and Refractory Period in Men With Overactive Bladder
NCT07736560
Ejaculation Abnormal, Female Urogenital Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsHEP® Tele-Rehabilitation for Preterm Infants at Developmental Risk: A Feasibility Study
NCT07727720
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Istanbul, Beykoz, Turkey (Türkiye)
View Trial Details